TXG 10x Genomics, Inc.
TXG 10x Genomics, Inc.
Healthcare · Health Information Services
Market read
Scan convergence 1 scan as of 2026-08-17 1 bull converging
POC $12.19 · VWAP $23.58 · +145.9% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
2 watchlists
TXG Price Structure
Loading timeframes…
Peers
Every watchlist TXG belongs to, members best 30-day change first — TXG highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech-capital-cycle
@ibb
Decision history
2 scored calls · newest first · projection
How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.
Against street estimates
How TXG's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
TXG research tape
17 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.
Desk commentary
Authored analysis and challenge notes tied to TXG.
Vertical: Biotech Capital Cycle — the theme is confirmed; the question is now entries
Obesity/GLP-1 vertical: the next-gen trade is an AI-discovery + tools barbell, not a pure drug-developer bet